Demand has catalyzed the development of Next Generation Sequencing technologies that deliver fast, inexpensive and accurate sequence information for genomic studies. Genomic medicine is a “game-changer” ushering in the path for personalized medicine at every stage of medical treatment, including patients, providers, researchers, payers, diagnostic companies, policy makers, life sciences and governments. Genomic medicine is rapidly becoming the foundation of innovative clinical trial protocols and the search for a new cadre of precision treatments that focus on preventing disease and alleviating symptoms.

For as long as they’ve been prescribing medicines, doctors have known that each patient responds to treatments in their own unique way. Pharmacogenomics, the study of how genetic variation contributes to an individual’s response to drugs, is an example of how genomics is becoming increasingly relevant in clinical decision-making.